CAT No: CP00727
CAS No: 144120-54-7
Synonyms/Alias: Fmoc-Glu-OAll;144120-54-7;(4S)-4-(9H-fluoren-9-ylmethoxycarbonylamino)-5-oxo-5-prop-2-enoxypentanoic acid;Fmoc-Glu-allyl ester;MFCD00467718;Fmoc-L-glutamic acid 1-allyl ester;1-Allyl N-Fmoc-L-glutamate;L-Glutamic acid, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-, 1-(2-propen-1-yl) ester;N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-glutamic-acid-alpha allyl ester;(S)-4-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-(allyloxy)-5-oxopentanoic acid;Fmoc-L-glutamic acid |A-allyl ester;1-(2-Propen-1-yl) hydrogen N-((9H-fluoren-9-ylmethoxy)carbonyl)-L-glutamate;1-(2-Propen-1-yl) hydrogen N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-glutamate;Fmoc-Glu-OAl;(4S)-4-{[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]AMINO}-5-OXO-5-(PROP-2-EN-1-YLOXY)PENTANOIC ACID;SCHEMBL10173082;DTXSID90427262;ORKKMGRINLTBPC-FQEVSTJZSA-N;AKOS015839131;AKOS015908508;AC-8590;CS-W008475;DS-8184;FF41629;HY-W008475;N-Fmoc-L-glutamic Acid 1-Allyl Ester;Fmoc-Glu-OAll, >=99.0% (HPLC);A2909;M06240;1-Allyl N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-glutamate;N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-glutamic Acid 1-Allyl Ester;(S)-4-(((9H-fluoren-9-yl)methoxy)carbonylamino)-5-(allyloxy)-5-oxopentanoic acid;852-966-5;
Quick InquiryCustom Peptide SynthesisPeptide Library Construction and Screening
Powerful screening tools in biological and chemical research
M.F/Formula | C23H23NO6 |
M.W/Mr. | 409.4 |
Sequence | One Letter Code:E Three Letter Code:Fmoc-Glu-Oallyl |
Abbr | Fmoc-Glu-OAll |
InChI | InChI=1S/C23H23NO6/c1-2-13-29-22(27)20(11-12-21(25)26)24-23(28)30-14-19-17-9-5-3-7-15(17)16-8-4-6-10-18(16)19/h2-10,19-20H,1,11-14H2,(H,24,28)(H,25,26)/t20-/m0/s1 |
InChI Key | ORKKMGRINLTBPC-FQEVSTJZSA-N |
Canonical SMILES | C=CCOC(=O)C(CCC(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13 |
1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Cationic cell-penetrating peptides are potent furin inhibitors
5. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at info@creative-peptides.com. We will endeavor to provide highly satisfying products and services.